What is Longevity?

Longevity just means a long life. In modern health science it means something more specific: stretching the good years, not just the total years.

The field goes by two names: longevity science, or geroscience. It studies how aging works at the cellular level. Researchers look for ways to slow, stop, or dial back the signs of it. This isn't about living forever. It's about living better for longer.

In the United States, life expectancy at birth climbed steeply during the 20th century. It went from about 47 years in 1900 (historical CDC data) to around 79 years as of 2024 (CDC/NCHS, "Mortality in the United States, 2024," released 29 January 2026), surpassing the previous record high of 78.9 years set in 2014. (Note: the December 2024 CDC release covered 2023 mortality, which landed at 78.4 years — still below the prior 2014 high; the 79-year all-time-high figure is specifically from the January 2026 release for 2024 data.) Most of that gain came from fewer infant deaths and fewer infections. The next frontier is extending healthy years in the second half of life.

Two words shape the whole longevity conversation.

Lifespan is how long you live. Total years, birth to death.

Healthspan is how long you live in good health. No chronic disease, no disability, mind still sharp.

The catch is that these two numbers often don't match. Many people spend their last 10 to 20 years dealing with heart disease, diabetes, dementia, or limited mobility. Longevity science isn't just about adding years to your life. It's about adding life to your years.

Research suggests genes account for a smaller share of lifespan than older twin studies implied. Those older estimates (Danish Twin Registry, Herskind 1996) landed around 25 percent. A much larger 2018 analysis drawing on over 400 million public family-tree records (Ruby et al., Genetics, 2018) concluded that once you account for people marrying similar partners, corrected lifespan heritability is well below 10 percent — far less than the older 25 percent figure. A 2026 Science paper (Shenhar et al., adz1187) argues the picture is more nuanced still: once you control for extrinsic mortality, intrinsic-lifespan heritability may be closer to 50 percent. Either way you have real control over both your lifespan and your healthspan — lifestyle agency remains large.

Caring about longevity isn't vanity. It's about being there for the moments that matter. The energy to chase grandkids. The clarity to pick up new interests after retirement. The strength to stay independent.

Zoom out and an aging global population brings both problems and openings. Health systems are stretched thin by chronic disease. If healthspan catches up to lifespan, we cut suffering, lower healthcare costs, and keep people contributing for longer.

The economics are striking. Modeling in Nature Aging (2021), "The Economic Value of Targeting Aging" by Scott, Ellison & Sinclair, looked at what it would be worth to slow aging. The answer: $37 trillion in net-present-value for the US economy from a slowdown in aging that adds one extra year of life expectancy (the paper argues such an intervention also compresses morbidity), rising to roughly $367 trillion in NPV for a slowdown that adds ten years — mostly by compressing end-of-life illness. Real-world outcomes would depend on many factors.

Maybe the best part is agency. Instead of treating decline as fixed, you can take evidence-based steps today. Those steps shape your health trajectory for decades.

Our picture of aging is shifting. What used to look like inevitable decline is now viewed as a biological process that can be nudged.

A few lines of research are driving the change.

Epigenetic clocks estimate biological age by reading DNA methylation patterns (chemical tags on your DNA that shift as you age). Studies suggest lifestyle changes may improve markers linked to cellular aging.

Senescent cell research has pinpointed zombie cells (old cells that refuse to die and drive inflammation). Drugs called senolytics can clear them in animal studies.

NAD+ research shows this key cellular molecule drops as we age. Early studies suggest that boosting it may support cell function. Long-term human data is still coming in.

AI and machine learning are speeding up drug discovery. They also help tailor interventions to an individual's markers (blood test numbers and other data).

We're still early. But the pace of discovery is picking up. Several approaches are already in early research and clinical testing. Results vary by intervention, and more long-term studies are needed.

The good news: you don't need to wait for new drugs or expensive treatments. The strongest longevity tools are already available.

Move regularly: Physical activity is the closest thing we have to a real longevity pill. Even moderate exercise is associated with a sharp drop in the risk of dying early.

Eat well: A diet built around plants, healthy fats, and lean proteins is linked to a longer life again and again. Mediterranean and Blue Zone patterns are the classic examples.

Sleep enough: Sleep is when your body does its repair work. Chronic sleep loss is linked to faster aging.

Stay connected: Strong social ties are one of the strongest predictors of a long life.

Manage stress: Ongoing stress is linked to faster cellular aging. Find what actually helps you wind down.

Know your numbers: Track key markers and understand your baseline. That way you can see what changes.

Start with one thing. Get it to stick. Then add another.

Your first 7 days — a starter block you can copy:

• Day 1: 30-minute walk outdoors.
• Day 2: Add 2 sets of 10 bodyweight squats and 10 pushups (knees if needed).
• Day 3: In bed with lights out by 23:00.
• Day 4: Fill half your lunch plate with vegetables.
• Day 5: Call or meet one friend you haven't seen recently.
• Day 6: 10 minutes outdoors without your phone.
• Day 7: Baseline measurements — weigh, measure waist, note resting pulse.

Free DACH prevention checks you are already paying for:

• Germany (GKV): Gesundheits-Check-Up from age 35, every 3 years — fasting glucose, lipid panel (total/LDL/HDL cholesterol, triglycerides), blood pressure, urine, history and exam. HbA1c is not part of the routine catalogue and is only added on indication. Ask for it.
• Austria: Annual Vorsorgeuntersuchung — broadly the same plus age-adjusted screening.
• Switzerland (LAMal): No routine annual GP check-up entitlement; LAMal basic insurance covers medically necessary GP visits after Franchise/Selbstbehalt.

These are already paid for. Use them before you self-pay for anything fancier.